Procept Biorobotics
PRCT
60 hedge funds and large institutions have $732M invested in Procept Biorobotics in 2021 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 23 closing their positions.
217% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 6
17% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 23
3% more funds holding
Funds holding: 58 → 60 (+2)
3.29% more ownership
Funds ownership: 64.41% → 67.7% (+3.3%)
29% less capital invested
Capital invested by funds: $1.03B → $732M (-$295M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DFO
Duquesne Family Office
New York
|
+$39.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$18.6M |
| 3 |
BlackRock
New York
|
+$11.1M |
| 4 |
Renaissance Technologies
New York
|
+$6.63M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$5.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$12.2M |
| 2 |
O
OrbiMed
New York
|
-$5.15M |
| 3 |
YRHAM
Yong Rong (HK) Asset Management
Sheung Wan,
Hong Kong
|
-$4.85M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$4.71M |
| 5 |
Goldman Sachs
New York
|
-$2.21M |
PRCT Hedge Fund Activity: Q4 2021 in Review
60 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Procept Biorobotics (PRCT) for Q4 2021, worth a combined $732M — down 29% from $1.03B a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new PRCT positions and 23 closed out — a net gain of 4 holders — while 19 added to existing stakes and 6 trimmed.
The largest buyer was Duquesne Family Office, adding an estimated $39.2M. The largest seller was Perceptive Advisors, cutting an estimated $12.2M.
- 60 institutional investors held Procept Biorobotics (PRCT) as of Q4 2021, up from 58 in Q3 2021.
- Funds reported $732M of Procept Biorobotics stock for Q4 2021, down 29% quarter-over-quarter.
- 27 funds opened new Procept Biorobotics positions in Q4 2021 and 23 closed out, a net change of +4 holders.
- The largest Procept Biorobotics buyer in Q4 2021 was Duquesne Family Office, an estimated $39.2M added.
- The largest Procept Biorobotics seller in Q4 2021 was Perceptive Advisors, an estimated $12.2M sold.
Based on aggregated 13F filings for Q4 2021.